ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
NCT04347473
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
Patient with moderate-to-severe plaque psoriasis will receive Ilumya with or without Halog ointment.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Psoriasis
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Psoriasis Treatment Center of Central New Jersey
- Last updated on ClinicalTrials.gov
- April 15, 2020
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
New Jersey · 1
- Psoriasis Treatment Center of Central New Jersey · East Windsor, NJ
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.